Pharmaceuticals & BiotechnologySmall Cap
Concord Biotech Limited
CONCORDBIO · ISIN: INE338H01029
Constituent of NIFTY 500 TRI (0.02%), NIFTY SC 250 TRI (0.22%)
Close (as of 2026-09-08)
₹1470.5
+1.89% today
Day Range
₹1437.8 - ₹1492
Quality Score (as of 2026-06-30)
75/100
Earnings (TTM)
CHART
Concord Biotech Limited - revenue & profit (TTM)
Trailing-twelve-month figures by reported quarter, in ₹ Cr. Latest quarter: 2026-06-30.
Revenue (TTM)PAT (TTM)
32.64%
EBITDA Margin (TTM)
26.09
EPS (TTM)
-
EPS Growth (5Y)
-
EPS Growth (10Y)
Technicals
52.85
RSI (14)
1395.18
SMA (50)
1266.25
SMA (200)
20.94
ADX (14)
1730
52-Week High
987
52-Week Low
-12.92%
1Y Return
24.4233
Avg Traded Value (20D, ₹Cr)
As of 2026-09-08.
Shareholding Pattern
CHART
Shareholding by category
As of 2026-06-30.
Promoter 44.08%Public 55.92%
Corporate Actions
No corporate actions on record for this stock.
Recent Deals
No recent block/bulk/short-sell deals on record for this stock.
Stock data · Not financial advice · Past performance does not indicate future returns